Concepedia

Rolf van Hes

RV

3

Publications

159

Citations

3

H-Index

1993

Active since

Affiliations

Solvay (Netherlands)(Current)

Rolf van Hes is an author at Solvay (Netherlands) specializing in social sciences, neuropharmacology, and medicine.

Top concepts

Publications per year

1993–2005

3

Publications

3

Development of high-affinity 5-HT3 receptor antagonists. Structure-affinity relationships of novel 1,7-annulated indole derivatives. 1

I. van Wijngaarden, D. Hamminga, Rolf van Hes et al. · Journal of Medicinal Chemistry · 1993 · 74 citations · Full text

Synthesis, Structure−Activity Relationships, and Biological Properties of 1-Heteroaryl-4-[ω-(1<i>H</i>-indol-3-yl)alkyl]piperazines, Novel Potential Antipsychotics Combining Potent Dopamine D<sub>2</sub> Receptor Antagonism with Potent Serotonin Reuptake Inhibition

Pieter Smid, Hein K. A. C. Coolen, Hiskias G. Keizer et al. · Journal of Medicinal Chemistry · 2005 · 58 citations · Full text

, , +18

SLV310, a novel, potential antipsychotic, combining potent dopamine D2 receptor antagonism with serotonin reuptake inhibition

Rolf van Hes, Pieter Smid, Cees N. J. Stroomer et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 27 citations · Full text

, , +9

Rows per page

1–3 of 3